MUSCAT – In an official announcement, the Ministry said the move follows the integration of the medical device and supplies establishment registration service with the national release system, a step aimed at strengthening regulatory oversight and ensuring the safety and quality of products in the market.

The directive, issued by the Directorate General of Pharmaceutical Affairs and Drug Control, applies to all owners and managers of companies and institutions in the sector. Firms have been instructed to expedite registration processes, comply fully with approved regulatory requirements before requesting shipment releases, and ensure alignment with applicable laws.

The six-month compliance window began from the issuance of Circular No. 15/2026 on February 16, after which unregistered establishments will no longer be able to release shipments, the Ministry warned.